Serina Therapeutics, Inc.
$2.25
Market Cap
$56.39M
Shares Outstanding
25.4M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Mar 27, 2024
Round Lot
100
Locale
US
Day Open
$2.20
Day High
$2.29
Day Low
$2.09
Volume
66.1K
VWAP
$2.21
Prev Close
$2.22
Transactions
--
Acc. Volume
--
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Serina Therapeutics, Inc. (SER) closed the 2026-09-18 session at $2.25, up 1.35% versus the previous close (+0.03). The stock opened at $2.20 and traded between $2.09 and $2.29 during that session. Session trading volume was 66K shares. The volume-weighted average price (VWAP) is $2.21.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Serina Therapeutics, Inc. has a market capitalization of $56.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SER is listed on the XASE exchange. The company employs approximately 16 people. Serina Therapeutics, Inc. is headquartered in HUNTSVILLE, AL. The recorded listing date is 2024-03-27.
On this page you can find market SER stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.